{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:08:46Z","timestamp":1791576526868,"version":"4.3.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T00:00:00Z","timestamp":1420675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T00:00:00Z","timestamp":1420675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1038\/leu.2015.4","type":"journal-article","created":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T07:34:28Z","timestamp":1420702468000},"page":"1115-1122","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":143,"title":["Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event"],"prefix":"10.1038","volume":"29","author":[{"given":"M","family":"Jawhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Schwaab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Schnittger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Sotlar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H-P","family":"Horny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Metzgeroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Naumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Walz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Haferlach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Valent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W-K","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N C P","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Fabarius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Reiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,8]]},"reference":[{"key":"BFleu20154_CR1","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","volume":"25","author":"P Valent","year":"2001","unstructured":"Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 2001; 25: 603\u2013625.","journal-title":"Leuk Res"},{"key":"BFleu20154_CR2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/ajh.23459","volume":"87","author":"A Pardanani","year":"2012","unstructured":"Pardanani A . Systemic mastocytosis in adults: 2012 Update on diagnosis, risk stratification, and management. Am J Hematol 2012; 87: 401\u2013411.","journal-title":"Am J Hematol"},{"key":"BFleu20154_CR3","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","volume":"37","author":"P Valent","year":"2007","unstructured":"Valent P, Akin C, Escribano L, Fodinger M, Hartmann K, Brockow K et al. Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest 2007; 37: 435\u2013453.","journal-title":"Eur J Clin Invest"},{"key":"BFleu20154_CR4","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jmoldx.2010.10.004","volume":"13","author":"T Kristensen","year":"2011","unstructured":"Kristensen T, Vestergaard H, Moller MB . Improved detection of the KIT D816V mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay. J Mol Diagn 2011; 13: 180\u2013188.","journal-title":"J Mol Diagn"},{"key":"BFleu20154_CR5","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1182\/blood-2006-04-015545","volume":"108","author":"AC Garcia-Montero","year":"2006","unstructured":"Garcia-Montero AC, Jara-Acevedo M, Teodosio C, Sanchez ML, Nunez R, Prados A et al. KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. Blood 2006; 108: 2366\u20132372.","journal-title":"Blood"},{"key":"BFleu20154_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00277-013-1964-1","volume":"93","author":"P Erben","year":"2014","unstructured":"Erben P, Schwaab J, Metzgeroth G, Horny HP, Jawhar M, Sotlar K et al. The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis. Ann Hematol 2014; 93: 81\u201388.","journal-title":"Ann Hematol"},{"key":"BFleu20154_CR7","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/path.2677","volume":"220","author":"K Sotlar","year":"2010","unstructured":"Sotlar K, Colak S, Bache A, Berezowska S, Krokowski M, Bultmann B et al. Variable presence of KITD816V in clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD). J Pathol 2010; 220: 586\u2013595.","journal-title":"J Pathol"},{"key":"BFleu20154_CR8","doi-asserted-by":"publisher","first-page":"4846","DOI":"10.1182\/blood-2011-12-397588","volume":"120","author":"E Soucie","year":"2012","unstructured":"Soucie E, Hanssens K, Mercher T, Georgin-Lavialle S, Damaj G, Livideanu C et al. In aggressive forms of mastocytosis, TET2 loss cooperates with c-KITD816V to transform mast cells. Blood 2012; 120: 4846\u20134849.","journal-title":"Blood"},{"key":"BFleu20154_CR9","doi-asserted-by":"publisher","first-page":"e43090","DOI":"10.1371\/journal.pone.0043090","volume":"7","author":"F Traina","year":"2012","unstructured":"Traina F, Visconte V, Jankowska AM, Makishima H, O'Keefe CL, Elson P et al. Single nucleotide polymorphism array lesions, TET2, DNMT3A, ASXL1 and CBL mutations are present in systemic mastocytosis. PLoS One 2012; 7: e43090.","journal-title":"PLoS One"},{"key":"BFleu20154_CR10","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1182\/blood-2013-04-496448","volume":"122","author":"J Schwaab","year":"2013","unstructured":"Schwaab J, Schnittger S, Sotlar K, Walz C, Fabarius A, Pfirrmann M et al. Comprehensive mutational profiling in advanced systemic mastocytosis. Blood 2013; 122: 2460\u20132466.","journal-title":"Blood"},{"key":"BFleu20154_CR11","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.1200\/JCO.2009.27.1361","volume":"28","author":"A Kohlmann","year":"2010","unstructured":"Kohlmann A, Grossmann V, Klein HU, Schindela S, Weiss T, Kazak B et al. Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1. J Clin Oncol 2010; 28: 3858\u20133865.","journal-title":"J Clin Oncol"},{"key":"BFleu20154_CR12","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/leu.2013.336","volume":"28","author":"T Haferlach","year":"2014","unstructured":"Haferlach T, Nagata Y, Grossmann V, Okuno Y, Bacher U, Nagae G et al. Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia 2014; 28: 241\u2013247.","journal-title":"Leukemia"},{"key":"BFleu20154_CR13","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1182\/blood-2012-01-404863","volume":"120","author":"M Meggendorfer","year":"2012","unstructured":"Meggendorfer M, Roller A, Haferlach T, Eder C, Dicker F, Grossmann V et al. SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML). Blood 2012; 120: 3080\u20133088.","journal-title":"Blood"},{"key":"BFleu20154_CR14","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1182\/blood-2013-11-537167","volume":"123","author":"P Lundberg","year":"2014","unstructured":"Lundberg P, Karow A, Nienhold R, Looser R, Hao-Shen H, Nissen I et al. Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms. Blood 2014; 123: 2220\u20132228.","journal-title":"Blood"},{"key":"BFleu20154_CR15","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/leu.2010.69","volume":"24","author":"A Tefferi","year":"2010","unstructured":"Tefferi A . Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1. Leukemia 2010; 24: 1128\u20131138.","journal-title":"Leukemia"},{"key":"BFleu20154_CR16","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1182\/blood-2011-02-292102","volume":"118","author":"W Vainchenker","year":"2011","unstructured":"Vainchenker W, Delhommeau F, Constantinescu SN, Bernard OA . New mutations and pathogenesis of myeloproliferative neoplasms. Blood 2011; 118: 1723\u20131735.","journal-title":"Blood"},{"key":"BFleu20154_CR17","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1182\/blood-2005-04-1568","volume":"106","author":"J Gotlib","year":"2005","unstructured":"Gotlib J, Berube C, Growney JD, Chen CC, George TI, Williams C et al. Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation. Blood 2005; 106: 2865\u20132870.","journal-title":"Blood"},{"key":"BFleu20154_CR18","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.iac.2014.01.009","volume":"34","author":"S Bibi","year":"2014","unstructured":"Bibi S, Langenfeld F, Jeanningros S, Brenet F, Soucie E, Hermine O et al. Molecular defects in mastocytosis: KIT and beyond KIT. Immunol Allergy Clin North Am 2014; 34: 239\u2013262.","journal-title":"Immunol Allergy Clin North Am"},{"key":"BFleu20154_CR19","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.cell.2012.02.028","volume":"148","author":"Y Hou","year":"2012","unstructured":"Hou Y, Song L, Zhu P, Zhang B, Tao Y, Xu X et al. Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm. Cell 2012; 148: 873\u2013885.","journal-title":"Cell"},{"key":"BFleu20154_CR20","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nbt.2283","volume":"30","author":"SC Bendall","year":"2012","unstructured":"Bendall SC, Nolan GP . From single cells to deep phenotypes in cancer. Nat Biotechnol 2012; 30: 639\u2013647.","journal-title":"Nat Biotechnol"},{"key":"BFleu20154_CR21","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/1479-5876-10-118","volume":"4","author":"M Jan","year":"2012","unstructured":"Jan M, Snyder TM, Corces-Zimmerman MR, Vyas P, Weissman IL, Quake SR et al. Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia. Sci Transl Med 2012; 4: 118\u2013149.","journal-title":"Sci Transl Med"},{"key":"BFleu20154_CR22","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cell.2013.01.019","volume":"152","author":"DA Landau","year":"2013","unstructured":"Landau DA, Carter SL, Stojanov P, McKenna A, Stevenson K, Lawrence MS et al. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell 2013; 152: 714\u2013726.","journal-title":"Cell"},{"key":"BFleu20154_CR23","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1038\/leu.2014.13","volume":"28","author":"L Melchor","year":"2014","unstructured":"Melchor L, Brioli A, Wardell CP, Murison A, Potter NE, Kaiser MF et al. Single-cell genetic analysis reveals the composition of initiating clones and phylogenetic patterns of branching and parallel evolution in myeloma. Leukemia 2014; 28: 1705\u20131715.","journal-title":"Leukemia"},{"key":"BFleu20154_CR24","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","volume":"122","author":"E Papaemmanuil","year":"2013","unstructured":"Papaemmanuil E, Gerstung M, Malcovati L, Tauro S, Gundem G, Van Loo P et al. Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood 2013; 122: 3616\u20133627.","journal-title":"Blood"},{"key":"BFleu20154_CR25","first-page":"291","volume-title":"Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues: World Health Organization (WHO) Classification of Tumours","author":"PHH Valent","year":"2001","unstructured":"Valent P HH, Li CY, Longley JB, Metcalfe DD, Parwaresch RM, Bennett JM . Mastocytosis. In: Elaine S, Jaffe NLH, Stein Harald, James WV (eds). Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues: World Health Organization (WHO) Classification of Tumours vol. 1. IARC Press: Lyon, France, 2001; pp 291\u2013302."},{"key":"BFleu20154_CR26","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S0145-2126(01)00021-2","volume":"25","author":"HP Horny","year":"2001","unstructured":"Horny HP, Valent P . Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings. Leuk Res 2001; 25: 543\u2013551.","journal-title":"Leuk Res"},{"key":"BFleu20154_CR27","first-page":"54","volume-title":"Tumours of Haematopoietic and Lymphoid Tissues","author":"HPAC Horny","year":"2008","unstructured":"Horny HP AC, Metcalfe DD, Swerdlow SH, Campo E, Harris NL et al. World Health Organization (WHO) Classification of Tumours. Mastocytosis (Mast cell disease). Pathology & Genetics. Tumours of Haematopoietic and Lymphoid Tissues vol. 2. Lyon, France: IARC Press, 2008; pp 54\u201363."},{"key":"BFleu20154_CR28","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.1002\/cncr.24440","volume":"115","author":"A Tefferi","year":"2009","unstructured":"Tefferi A, Thiele J, Vardiman JW . The 2008 World Health Organization classification system for myeloproliferative neoplasms: order out of chaos. Cancer 2009; 115: 3842\u20133847.","journal-title":"Cancer"},{"key":"BFleu20154_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000353118","volume":"141","author":"A Simons","year":"2013","unstructured":"Simons A, Shaffer LG, Hastings RJ . Cytogenetic nomenclature: changes in the ISCN 2013 compared to the 2009 Edition. Cytogenet Genome Res 2013; 141: 1\u20136.","journal-title":"Cytogenet Genome Res"},{"key":"BFleu20154_CR30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/sj.leu.2402329","volume":"16","author":"C Schoch","year":"2002","unstructured":"Schoch C, Schnittger S, Bursch S, Gerstner D, Hochhaus A, Berger U et al. Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases. Leukemia 2002; 16: 53\u201359.","journal-title":"Leukemia"},{"key":"BFleu20154_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-1-62703-357-2_4","volume":"999","author":"K Sotlar","year":"2013","unstructured":"Sotlar K . c-Kit mutational analysis in paraffin material. Methods Mol Biol 2013; 999: 59\u201378.","journal-title":"Methods Mol Biol"},{"key":"BFleu20154_CR32","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1136\/mp.53.4.188","volume":"53","author":"K Sotlar","year":"2000","unstructured":"Sotlar K, Marafioti T, Griesser H, Theil J, Aepinus C, Jaussi R et al. Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia. J Clin Pathol Mol Pathol 2000; 53: 188\u2013193.","journal-title":"J Clin Pathol Mol Pathol"},{"key":"BFleu20154_CR33","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1182\/blood-2012-06-440347","volume":"121","author":"R Itzykson","year":"2013","unstructured":"Itzykson R, Kosmider O, Renneville A, Morabito M, Preudhomme C, Berthon C et al. Clonal architecture of chronic myelomonocytic leukemias. Blood 2013; 121: 2186\u20132198.","journal-title":"Blood"},{"key":"BFleu20154_CR34","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1038\/leu.2008.233","volume":"22","author":"R Kralovics","year":"2008","unstructured":"Kralovics R . Genetic complexity of myeloproliferative neoplasms. Leukemia 2008; 22: 1841\u20131848.","journal-title":"Leukemia"},{"key":"BFleu20154_CR35","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1038\/leu.2013.119","volume":"27","author":"AM Vannucchi","year":"2013","unstructured":"Vannucchi AM, Lasho TL, Guglielmelli P, Biamonte F, Pardanani A, Pereira A et al. Mutations and prognosis in primary myelofibrosis. Leukemia 2013; 27: 1861\u20131869.","journal-title":"Leukemia"},{"key":"BFleu20154_CR36","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1046\/j.1365-2567.1996.493578.x","volume":"87","author":"H Agis","year":"1996","unstructured":"Agis H, Fureder W, Bankl HC, Kundi M, Sperr WR, Willheim M et al. Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes. Immunology 1996; 87: 535\u2013543.","journal-title":"Immunology"},{"key":"BFleu20154_CR37","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.4049\/jimmunol.151.8.4221","volume":"151","author":"H Agis","year":"1993","unstructured":"Agis H, Willheim M, Sperr WR, Wilfing A, Kromer E, Kabrna E et al. Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c-kit+, CD34+, Ly-, CD14-, CD17-, colony-forming cell. J Immunol 1993; 151: 4221\u20134227.","journal-title":"J Immunol"},{"key":"BFleu20154_CR38","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/leu.2011.10","volume":"25","author":"V Grossmann","year":"2011","unstructured":"Grossmann V, Kohlmann A, Eder C, Haferlach C, Kern W, Cross NC et al. Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance. Leukemia 2011; 25: 877\u2013879.","journal-title":"Leukemia"},{"key":"BFleu20154_CR39","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1182\/blood-2010-03-274704","volume":"116","author":"AE Smith","year":"2010","unstructured":"Smith AE, Mohamedali AM, Kulasekararaj A, Lim Z, Gaken J, Lea NC et al. Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value. Blood 2010; 116: 3923\u20133932.","journal-title":"Blood"},{"key":"BFleu20154_CR40","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.3324\/haematol.2012.075325","volume":"98","author":"SA Mian","year":"2013","unstructured":"Mian SA, Smith AE, Kulasekararaj AG, Kizilors A, Mohamedali AM, Lea NC et al. Spliceosome mutations exhibit specific associations with epigenetic modifiers and proto-oncogenes mutated in myelodysplastic syndrome. Haematologica 2013; 98: 1058\u20131066.","journal-title":"Haematologica"},{"key":"BFleu20154_CR41","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1056\/NEJMra0902908","volume":"361","author":"A Tefferi","year":"2009","unstructured":"Tefferi A, Lim KH, Levine R . Mutation in TET2 in myeloid cancers. N Engl J Med 2009; 361: 1117\u20131118.","journal-title":"N Engl J Med"},{"key":"BFleu20154_CR42","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1200\/JCO.2012.47.3314","volume":"31","author":"R Itzykson","year":"2013","unstructured":"Itzykson R, Kosmider O, Renneville A, Gelsi-Boyer V, Meggendorfer M, Morabito M et al. Prognostic score including gene mutations in chronic myelomonocytic leukemia. J Clin Oncol 2013; 31: 2428\u20132436.","journal-title":"J Clin Oncol"},{"key":"BFleu20154_CR43","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1136\/jcp.2003.014860","volume":"57","author":"HP Horny","year":"2004","unstructured":"Horny HP, Sotlar K, Sperr WR, Valent P . Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge. J Clin Pathol 2004; 57: 604\u2013608.","journal-title":"J Clin Pathol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu20154.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu20154","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu20154.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T16:59:22Z","timestamp":1690822762000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu20154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,8]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["BFleu20154"],"URL":"https:\/\/doi.org\/10.1038\/leu.2015.4","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,8]]},"assertion":[{"value":"24 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S Schnittger and TH have equity ownership of MLL Munich Leukemia Laboratory GmbH. The remaining authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}